BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/6/2024 6:10:51 AM | Browse: 175 | Download: 456
 |
Received |
|
2023-11-26 01:15 |
|
Peer-Review Started |
|
2023-11-26 01:16 |
|
First Decision by Editorial Office Director |
|
2023-12-25 05:25 |
|
Return for Revision |
|
2023-12-25 05:25 |
|
Revised |
|
2023-12-28 00:54 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-02-05 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-02-05 05:04 |
|
Articles in Press |
|
2024-02-05 05:04 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-02-26 05:48 |
|
Publish the Manuscript Online |
|
2024-03-06 06:10 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Joseph Edwin Kanu and Jonathan Soldera |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jonathan Soldera, MD, PhD, Instructor, Post Graduate Program at Acute Medicine and Gastroenterology, University of South Wales, Llantwit Rd, Pontypridd, Cardiff CF37 1DL, United Kingdom. jonathansoldera@gmail.com |
| Key Words |
Helicobacter pylori infection; Potassium competitive acid blockers; Proton pump inhibitors; Vonoprazan; Amoxicillin |
| Core Tip |
In the systematic review and meta-analysis on the treatment of Helicobacter pylori with potassium competitive acid blockers (P-CABs), vonoprazan-based triple therapy demonstrated superior efficacy over conventional proton pump inhibitor (PPI)-based triple therapy, establishing itself as a highly effective first-line regimen. Conversely, tegoprazan-based triple therapy was found to be non-inferior to classical PPI triple therapy. These findings signify a potential paradigm shift in H. pylori eradication strategies. |
| Publish Date |
2024-03-06 06:10 |
| Citation |
Kanu JE, Soldera J. Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis. World J Gastroenterol 2024; 30(9): 1213-1223 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i9/1213.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i9.1213 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
